Search Results - Michael Postow

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Response after treatment with pembrolizumab in a patient with myelophthisis due to melanoma: the role of checkpoint inhibition in the bone by Samuel Rosner, Filiz Sen, Michael Postow

    Published in Journal for ImmunoTherapy of Cancer (2017-04-01)
    Get full text
    Article


  2. 2

    Ensuring equity in the era of HLA-restricted cancer therapeutics by Michael Postow, James W Smithy, Amanda Blouin, Lisa C Diamond

    Published in Journal for ImmunoTherapy of Cancer (2022-11-01)
    Get full text
    Article


  3. 3

    Adjuvant systemic therapy in melanoma: Relative versus absolute benefit; the number needed to treat (NNT) versus the number needed to harm (NNH)? by Alexander C.J. van Akkooi, Mario Mandala, Paul Nathan, Andrew Haydon, Michael Postow, Piotr Rutkowski

    Published in EJC Skin Cancer (2024-12-01)
    Get full text
    Article


  4. 4

    Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors by Amitabh Srivastava, Michael Postow, David Faleck, Patrick Tiongco Magahis, Tara Corso, Pamela Livingstone, Erika Tom

    Published in Journal for ImmunoTherapy of Cancer (2024-07-01)
    Get full text
    Article


  5. 5

    135 Integration of T-cell activation and tumor mutation burden predicts anti-PD-1 response by Matthew Adamow, Katherine S Panageas, Michael Postow, Margaret K Callahan, James W Smithy, Ronglai Shen, Fiona Ehrich, Colleen Maher, Jasme Lee, Xiyu Peng, Samuel A Funt, Niamh Keegan

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  6. 6

    Recent Advances in the Field of Artificial Intelligence for Precision Medicine in Patients with a Diagnosis of Metastatic Cutaneous Melanoma by Hayley Higgins, Abanoub Nakhla, Andrew Lotfalla, David Khalil, Parth Doshi, Vandan Thakkar, Dorsa Shirini, Maria Bebawy, Samy Ammari, Egesta Lopci, Lawrence H. Schwartz, Michael Postow, Laurent Dercle

    Published in Diagnostics (2023-11-01)
    Get full text
    Article


  7. 7

    Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy by Michael Postow, Igor Puzanov, Suthee Rapisuwon, Michael A. Davies, Zeynep Eroglu, Eileen Shiuan, Kathryn E. Beckermann, Alpaslan Ozgun, Ciara Kelly, Meredith McKean, Jennifer McQuade, Mary Ann Thompson, John P. Greer, Douglas Johnson

    Published in Journal for ImmunoTherapy of Cancer (2017-08-01)
    Get full text
    Article


  8. 8

    Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis by Isabella Sala, Isabella Sala, Eleonora Pagan, Laura Pala, Chiara Oriecuia, Chiara Oriecuia, Marco Musca, Marco Musca, Claudia Specchia, Tommaso De Pas, Javier Cortes, Javier Cortes, Javier Cortes, Giuseppe Giaccone, Michael Postow, Richard D. Gelber, Vincenzo Bagnardi, Fabio Conforti, Fabio Conforti

    Published in Frontiers in Immunology (2024-01-01)
    Get full text
    Article


Search Tools: